TAIWAN BIO THERAPEUTICS CO., LTD

Highlights Taiwan Bio Therapeutics Co., Ltd

Equities

6892

TW0006892003

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
52.6 ^TWD	-4.54%		+28.14%	+53.35%

Mar. 12	TRACT Therapeutics and Taiwan Bio Therapeutics Announce to Launch Phase 2 Clinical Trial Investigating Ability of Treg Therapy to Reduce Use of Immunosuppressant Drugs in Living Donor Kidney Transplant Recipients	CI
2023	Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TRACT Therapeutics and Taiwan Bio Therapeutics Announce to Launch Phase 2 Clinical Trial Investigating Ability of Treg Therapy to Reduce Use of Immunosuppressant Drugs in Living Donor Kidney Transplant Recipients	Mar. 12	CI
Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant	Dec. 06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Secure my Investments

fermer